Inactive Instrument

News Enzon Pharmaceuticals Inc Nasdaq

Equities

US2939041081

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Mar. 20	Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-05-05	AQ
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05	CI
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-02-16	AQ
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-16	CI
ENZON PHARMACEUTICALS, INC. : Other Events (form 8-K)	23-01-06	AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-09	AQ
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-04	AQ
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04	CI
ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-06-15	AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-04-26	AQ
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-02-25	AQ
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21-11-05	AQ
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-05	CI
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21-08-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Enzon Pharmaceuticals Inc Nasdaq

Equities

US2939041081

Summary

Filters